Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Patients with NF1-PN
.
Show all posts
Showing posts with label
Patients with NF1-PN
.
Show all posts
Friday, November 7, 2025
FDA Approves Gomekli (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
›
SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, anno...
›
Home
View web version
